DOMA Perpetual Calls for Immediate Sale Exploration of Pacira BioSciences DOMA Perpetual Capital Management has urged Pacira BioSciences' board to hire bankers and explore a sale process, citing poor performance and excessive spending.

DOMA Perpetual Calls for Immediate Sale Exploration of Pacira BioSciences #USA #Miami #Pacira_BioSciences #Exparel #DOMA_Perpetual

Shareholders Foundation Announces Lawsuit for Pacira BioSciences, Inc. Investors Amid Patent Controversies A lawsuit has been filed against Pacira BioSciences, Inc. by investors following troubling revelations regarding patent protections for Exparel, vital for the company's growth.

Shareholders Foundation Announces Lawsuit for Pacira BioSciences, Inc. Investors Amid Patent Controversies #United_States #San_Diego #Securities_Law #Pacira_BioSciences #Exparel

Robbins LLP Alerts Investors of Pacira BioSciences Class Action Lawsuit Details Robbins LLP has announced the filing of a class action lawsuit against Pacira BioSciences, shedding light on critical investor issues and stock performance.

Robbins LLP Alerts Investors of Pacira BioSciences Class Action Lawsuit Details #USA #San_Diego #Robbins_LLP #Pacira_BioSciences #Exparel